HALO
Halozyme Therapeutics, Inc. · Healthcare
Director Bernadette Connaughton sold $125K of Halozyme Therapeutics, Inc.
Sold$124,651
$76.71Price
1,625Shares
−4%Stake
What HALO did after the filing
- The stock from Mon, Jul 6 open, $79.17
- +32.5%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Aug 18 close.
Traded Wed, Jul 1. Filed Thu, Jul 2, 4:42 PM ET, after the close. Returns use the Jul 6 open and the Aug 18 close. Not investment advice.